Abatacept homecare for Northern Trust patients comes from Lloyds Clinical
- Northern Health and Social Care Trust
- Northern Ireland
- Direct award
- 2 June 2026 to 31 May 2029
Northern Health and Social Care Trust buys Abatacept (Orencia) from Lloyds Clinical, which delivers the medicine to patients at home.
Alongside the deliveries, the firm gives clinical support and monitors patients, working with hospital pharmacy departments to keep care continuous. Abatacept is a biological therapy, so it needs cold-chain storage and handling.
The trust awarded the £3m contract directly in May 2026, for up to three years. It is due to end in May 2029.
Contract ends May 2029
- What
- Homecare medicines services
- Supplier
- Lloyds Clinical
- Value
- £3m
- How it was bought
- Direct award
- Dates and next
- Jun 2026 to May 2029